News

Eye screening varied from 31.8% - 73.0%, with lower screening rates at smaller health systems.

Patients with severe eosinophilic asthma who stopped treatment also experienced reduced asthma control and shorter times for clinically significant exacerbations.

New data show "nocebo responses" are frequent in COVID-19 vaccine studies—which may drive recipients' expectation of side effects.

The Prevalence of inflammatory bowel disease is highest in the Western world.

Dr. Siddharthan speaks of high COPD rates in low- and middle-income countries with increased environmental exposures and a lack of diagnostic tools.

The 6 recommendations across 2 expert-led guidelines address the role of colonoscopy, CT scans and elective surgery, among other subjects of care.

Out-of-pocket costs for noninsulin medications were 84.4% to 95.2% lower in Medicaid than in Marketplace plans, while out-of-pocket costs for insulin were 76.7% to 94.7% lower.

Swedish investigators noted differences in the prevalence of atopic dermatitis among the 2 sexes, and considered it important data for clinicians that treat patients with the disease.

After conducting and extensive literary review on all eligible data regarding COVID-19 in patients with sickle cell disease or trait, experts discuss what is known and what needs to be better understood about the pandemic's effect on this population.

Investigators believe drugs like etanercept and ustekinumab could reduce the risk of psoriatic arthritis in patients with moderate-to-severe chronic plaque psoriasis.

About 25% of C difficile infections are due to community spread.

From a new heart failure indication to a first-of-its-kind rare disease treatment, here's the most interesting PDUFA dates for the first half of the year.

Investigators in China observed a substantial decrease in the number of severe cases after the arrival of the EV-A71 vaccine.

Data show the 1-year incidence of the composite primary endpoint was 10.6% among patients randomized to FFR-guided PCI and 6.9% in CABG.

Optical treatment with DIMS was significantly associated with slower myopia progression compared to SVL treatment during the lockdown period.

The newest venture from Mount Sinai is intended to build a pipeline of physician-scientists.

More than 70% of parents of children with asthma said they in favor of the influenza vaccine during the COVID-19 pandemic.

Investigators conducted an extensive literature review on clinical COVID-19 outcomes in patients with SCD or SCT to better navigate treatment during the pandemic.

The decision was supported by 5 clinical trials that resulted in significant improvements in skin clearance, extent of disease, and severity.

Regina Hartfield is the new CEO and president of the Sickle Cell Association of America. Listen to our interview with her to find out what's in store for 2022.

Upadacitinib is now indicated for children 12 years and older, and can be used as a monotherapy or with topical corticosteroids.

Baez-Sosa explains why further investigation of alloimmunization in patients with sickle cell disease is crucial.

Exciting new therapies for sickle cell disease are on the horizon. We explored some of the most promising investigational therapies in recognition of National Blood Donor Month.

Beach shares about Haywood's life, research, and impact on the sickle cell disease community after working alongside him at Johns Hopkins School of Medicine.

Achebe explains the promising results of the open label extension to the HOPE trial for patients with sickle cell disease.

Sexual activity was involved in 0.2% of all SCDs, with sudden arrhythmic death syndrome and cardiomyopathies predominant underlying causes.

Exposure to long-term prescription opioid therapy was linked to a 3.2-fold higher risk of HCV seroconversion compared to individuals who were prescription opioid-naïve or acute.

Trials of CBP-201 for asthma and chronic rhinosinusitis with nasal polyps are ongoing, and early data from the atopic dermatitis trial were promising.

The study suggests a platform that can be integrated into surgical ophthalmic microscopes can provide real-time audiovisual feedback to the surgeon during phacoemulsification cataract surgery.

Brexipiprazole has been previously approved for adults with schizophrenia and adults with major depressive disorder.